Jan Geissler is founder and managing director of Patvocates, a think tank and consultancy in patient advocacy, acting as advisor on patient advocacy, health policy and social media. For the past 6 years, he has been working for the European Patients’ Forum as the Director of the ‘European Patients Academy on Therapeutic Innovation’ (EUPATI), a project funded by Innovative Medicines Initiative. EUPATI has developed educational material and training courses to educate patient and patient advocates about medicines development processes. He continues to be responsible for EUPATI’s future evolution. He is also coordinator of the work package of the new IMI big data project HARMONY, coordinating stakeholder input from patient organisations, HTA bodies, regulators and other stakeholders. After his university diploma in Business studies in the UK and Germany in 1999, Jan held various management positions in telecom, R&D and media think tanks before he focused his professional life on patient advocacy in 2008. Being a leukemia survivor who took part in various clinical trials, Jan founded the online patient community Leukaemie-Online.de in 2002. In 2003, he co-founded the European Cancer Patient Coalition. In 2007, Jan also co-founded the CML Advocates Network connecting 113 leukemia patient groups from 83 countries today. He is representing patients in various advisory boards, committees and expert groups e.g. of the European Commission (European Commission Expert Groups on Cancer Control and Rare Diseases), ECCO (Patient Advisory Committee), ESMO (Patient Advocacy Working Group), EORTC (Institutional Review Board) and the International CML Foundation (Scientific Advisory Board). He is also a member of the European Hematology Association’s European Affairs Committee.